title: Can cytotoxic drugs cure subacute sclerosing panencephalitis?
authors.forename: S
authors.initials: S
authors.lastname: al Rajeh
authors.forename: M M
authors.initials: MM
authors.lastname: Kabiraj
authors.forename: I
authors.initials: I
authors.lastname: al Fawaz
authors.forename: A K
authors.initials: AK
authors.lastname: Daif
authors.forename: A
authors.initials: A
authors.lastname: al Jarallah
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications; D011239:Prednisolone / Q000627:therapeutic use; D012074:Remission Induction; D013344:Subacute Sclerosing Panencephalitis / Q000150:complications / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D011239:Prednisolone; D001215:Asparaginase